Allozymes Newsletter

Allozymes is a cutting-edge biotechnology company specializing in the development and production of high-quality enzymes for various industries. 

Allozymes proprietary microfluidics technology is primarily designed around ultrahigh throughput screening. To engineer enzymes, we combine single site saturation mutagenesis followed by combinatorial libraries and screen millions of variants. Our in vitro strategy is supported by an in silico platform fed by a huge amount of data generating robust and reliable models.